Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20824184 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells.
Condition: Prostate Cancer
Interventions: Biological: vaccine vehicle only;   Biological: DC/LNCaP

Indicates status has not been verified in more than two years